Erratum to: Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

被引：0
|
作者：
Howard Lee
机构：
[1] Seoul National University Hospital,Clinical Trials Center, Department of Clinical Pharmacology and Therapeutics
来源：
The AAPS Journal | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1520 / 1521
页数：1
相关论文
共 19 条
  • [1] Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
    Lee, Howard
    AAPS JOURNAL, 2014, 16 (01): : 22 - 26
  • [2] Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?
    Howard Lee
    The AAPS Journal, 2014, 16 : 22 - 26
  • [3] Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars? (vol 16, pg 22, 2014)
    Lee, Howard
    AAPS JOURNAL, 2015, 17 (06): : 1520 - 1521
  • [4] Adequacy of safety data for regulatory approval of pediatric indication through extrapolation algorithm
    Park, Min Soo
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (02) : 73 - 77
  • [5] Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
    Lu, XiaoQin
    Hu, Rui
    Peng, Lin
    Liu, MengSi
    Sun, Zhen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Extrapolation of Adjunctive Efficacy and Safety Data from Phase III Partial Epilepsy Trials to Evaluate Perampanel as Monotherapy
    Mintzer, Scott
    French, Jacqueline
    Williams, Betsy
    Patten, Anna
    Laurenza, Antonio
    NEUROLOGY, 2018, 90
  • [7] Efficacy and safety of biosimilars of anti-TNF-a in paediatric-onset Inflammatory Bowel Disease: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
    Dipasquale, V.
    Pellegrino, S.
    Cucinotta, U.
    Citrano, M.
    Graziano, F.
    Cappello, M.
    Busacca, A.
    Orlando, A.
    Accomando, S.
    Romano, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I419 - I419
  • [8] Efficacy and safety of biosimilars of anti-TNF-a in paediatric-onset Inflammatory Bowel Disease: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
    Dipasquale, V.
    Pellegrino, S.
    Cucinotta, U.
    Citrano, M.
    Graziano, F.
    Cappello, M.
    Busacca, A.
    Orlando, A.
    Accomando, S.
    Romano, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I419 - I419
  • [9] Prevalence, safety and efficacy of different antithrombotic regimens in patients with indication for warfarin discharged after coronary stenting: data from the WAR-STENT Pilot Registry
    Rubboli, A.
    Capecchi, A.
    Franco, N.
    Valencia, J.
    La Vecchia, L.
    Colletta, M.
    Costa, F.
    Di Pasquale, G.
    EUROPEAN HEART JOURNAL, 2008, 29 : 779 - 779
  • [10] EFFICACY AND SAFETY OF BIOSIMILARS OF ANTI-TNF-APLHA IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD)
    Dipasquale, V
    Pellegrino, S.
    Ventimiglia, M.
    Cucinotta, U.
    Citrano, M.
    Graziano, F.
    Cappello, M.
    Busacca, A.
    Orlando, A.
    Accomando, S.
    Romano, C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S141 - S142
12